⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 1, 2023JAMA Network OpenOpen Access

Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes

Ashwin Nayak Sharif Vakili Kristen Nayak Margaret C. Nikolov Michelle Chiu Philip Sosseinheimer Sarah Talamantes Stefano Testa Srikanth Palanisamy Vinay K. Giri Kevin A. Schulman

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the effectiveness of voice-based AI in managing basal insulin prescriptions for individuals with type 2 diabetes.
Study of patients with type 2 diabetes utilizing voice-based AI for insulin management.
ClinicalTrials.gov Identifier: NCT05081011.
Improvements in insulin management efficiency were observed among patients using the voice-based AI.
Further quantitative results are pending publication.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Assesses voice-based AI for managing basal insulin in type 2 diabetes patients, suggesting efficiency improvements.

Abstract

ClinicalTrials.gov Identifier: NCT05081011.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nayak et al. (2023) studied this question.

synapsesocial.com/papers/69d6c1bcf174babf6cab365a https://doi.org/10.1001/jamanetworkopen.2023.40232

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1821-P: Comparison of In-Hospital Glucose Management of People with Type 2 Diabetes Made by Artificial Intelligence Chatbot vs. Physicians—A Cross-Sectional Study2024 · 2 citations
22020-P: Communication as a Modifiable Factor in Insulin Inertia: An Analysis of Mock Consultations Using ConversationAIlyClinical Guideline · 2026
3Interactive Artificial Intelligence Interventions for Diabetes ManagementOriginal Research · 2026
4Clinical Effectiveness, Safety, and Implementation of Artificial Intelligence-Assisted Insulin Management Systems in Type 1 and Type 2 Diabetes: A Systematic Review of Randomized Controlled TrialsSystematic Review · 2026
5Nurse-in-the-Loop Artificial Intelligence for Precision Management of Type 2 Diabetes in a Clinical Trial Utilizing Transfer-Learned Predictive Digital Twin (Preprint)2024 · 10 citations
61054-OR: Mitraa-T1D: A Multicenter Randomized Trial of a Digital Conversational Support Tool in Adults with Type 1 DiabetesRCT · 2026
71103-P: The Mobile Insulin Titration Intervention to Transition from Basal Insulin to a GLP1-RA (MITI-GLP1)—Using Daily SMS Text Messages and Weekly Phone Calls to Transition Primary Care Patients with Well-Controlled Type 2 Diabetes Mellitus from Basal Insulin to a GLP1-RA at Bellevue Hospital2024
8My diabetes care: an AI-based mobile app with conversational agent for type 2 diabetes self-management2025
9Coal-Fired Power Plants and the Adverse Social Exposome—Where Advantage Is Absent, Burden AccumulatesJAMA Network Open · 2026
10Fragile X Syndrome Diagnosis Patterns in a Multistate, Population-Based CohortJAMA Network Open · 2026

More from JAMA Network Open

More from Stanford University

More from Stanford Medicine